Franklin Resources’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Franklin Resources’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,025,540	Closed	-$5.16M	–	1650
2014 Q3	$5.16M	Sell	1,025,540 -62,579	-6%	-$385K	﹤0.01%	1177
2014 Q2	$7.3M	Sell	1,088,119 -1,427,825	-57%	-$9.09M	﹤0.01%	1109
2014 Q1	$18.2M	Buy	2,515,944 +341,800	+16%	+$2.03M	0.01%	877
2013 Q4	$8.2M	Hold	2,174,144	–	–	﹤0.01%	1032
2013 Q3	$7.28M	Buy	+2,174,144	New	+$7.57M	﹤0.01%	1040

Other funds holding NWBO

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources's NWBO Position: Q4 2014 in Review

Franklin Resources sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2014, closing a stake of 1,025,540 shares — an estimated $5.16M sold.

Franklin Resources first reported a position in NWBO in Q3 2013 and held it in 5 quarters. The position peaked at $18.2M in Q1 2014. 70 funds tracked by Wall St. Rank hold NWBO as of Q4 2014.

Franklin Resources reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2014 after selling out during the quarter.
Franklin Resources sold 1,025,540 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2014, an estimated $5.16M.
Franklin Resources first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2013 and held it in 5 quarters.
Franklin Resources's Northwest Biotherapeutics, Inc. Common stock position peaked at $18.2M in Q1 2014.
70 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2014.

Based on Franklin Resources's 13F filing for Q4 2014, filed 10 Feb 2015.